Enclosed is the intimation of earnings conference call - Q1 2026-27 results.

July 31, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Earnings Conference Call on Q1 FY 2026-27 Results – Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (“SEBI LODR Regulations”) Pursuant to Regulation 30 of the SEBI LODR Regulations, we are enclosing herewith the schedule and details of Earnings Conference Call to be held on Thursday, August 6, 2026. This is for your information and records. Thanking you. Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Schedule and details of Earnings Conference Call Q1 FY 2026-27 Results Conference Call Day and Date Thursday, August 6, 2026 Time 8:30 AM hrs. (India Standard Time) Dial-in Numbers Universal Access +91 22 6280 1144/ +91 22 7115 8045 International Toll-Free Numbers USA : 1 866 746 2133 UK : 0 808 101 1573 Singapore : 800 101 2045 Hong Kong : 800 964 448 Participant link Click here Diamond Pass registration link Click here to register Contact: Investor Relations Saransh Mundra E-Mail: investor_relations@ikshealth.com